Anzeige
Mehr »
Samstag, 01.08.2026 - Börsentäglich über 12.000 News
SEAS meldet US-Compliance: Kobalt-Ziele in zwei Ozeanen im Fokus
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P5KA | ISIN: CA75671E1097 | Ticker-Symbol: 4YX
München
31.07.26 | 09:49
0,019 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
RED LIGHT HOLLAND CORP Chart 1 Jahr
5-Tage-Chart
RED LIGHT HOLLAND CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0120,02431.07.

Aktuelle News zur RED LIGHT HOLLAND Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoCSE Bulletin: Name and Symbol Change - Red Light Holland Corp. (TRIP)82Le 30 juillet/July 2026 Red Light Holland Corp. (TRIP) has announced a name and symbol change to Rhelion Life Sciences Corp. (RELH). Shares will begin trading under the new name and symbol and...
► Artikel lesen
RED LIGHT HOLLAND Aktie jetzt für 0€ handeln
MiRed Light Holland reports FY results4
MiRed Light Holland Corp.: Red Light Holland Reports Fiscal 2026 Audited Year-End Results and Provides Update on Rhelion Life Sciences268Toronto, Ontario--(Newsfile Corp. - July 29, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based organization advancing...
► Artikel lesen
17.07.Red Light Holland Corp: Red Light to change name to Rhelion Life Sciences2
17.07.Red Light Holland to rebrand to Rhelion Life Sciences3
17.07.Red Light Holland Corp.: Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp400Rhelion Life Sciences reflects the Company's evolution into a sharpened focused, science-driven life sciences platform dedicated to psychedelic drug discovery, development, and innovationToronto...
► Artikel lesen
17.07.Red Light Holland Corp: Red Light's Filament completes PEX010 shipment into EU6
16.07.Red Light Holland Corp.: Red Light Holland Announces New Filament Health PEX010 European Research Shipment440Toronto, Ontario--(Newsfile Corp. - July 16, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization...
► Artikel lesen
09.07.Red Light Holland Corp: Red Light's Filament offers 0.5 mg dose of PEX0104
08.07.Red Light Holland Corp.: Red Light Holland Announces Filament Health's Largest-Ever Manufacturing Run of PEX010, the Standardized and Patented Natural Psilocybin Drug Candidate Trusted Across 80+ Studies Globally, Now Offering the Widest Standardized Dosi287Filament Health has commenced the largest production run in its history of its standardized, patented PEX010 botanical psilocybin drug candidate, introducing a new 0.5 mg dose alongside its existing...
► Artikel lesen
08.07.Red Light Holland Corp: Red Light Holland's Filament to supply PEX010 to ARQ7
07.07.Red Light Holland Corp.: Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Military Veterans PTSD Study at ARQ National Psychotrauma Centre397Toronto, Ontario--(Newsfile Corp. - July 7, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization...
► Artikel lesen
18.06.Red Light Holland reports coca leaf extract study results6
18.06.Red Light Holland meldet Studienergebnisse zu Kokablatt-Extrakt mit Potenzial bei Gewichtskontrolle3
18.06.Red Light Holland Corp.: Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health346Whole leaf coca extract under evaluation is Magdalena's drug candidate for post GLP-1 weight loss managementToronto, Ontario--(Newsfile Corp. - June 18, 2026) - Red Light Holland Corp. (CSE: TRIP)...
► Artikel lesen
08.06.Red Light Holland Corp: Red Light's Filament to supply PEX010 for French group9
08.06.Red Light Holland Corp.: Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in France437Toronto, Ontario--(Newsfile Corp. - June 8, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization...
► Artikel lesen
04.06.Red Light Holland Corp: Red Light Holland's psilocybin selected for UCSF study5
04.06.Red Light Holland Corp.: Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markers538Filament Health will supply its standardized, patented PEX010 botanical psilocybin drug candidate, produced using proprietary extraction and stabilization methods to an independently sponsored UCSF...
► Artikel lesen
25.05.Red Light Holland Corp: Red Light expands NZ psilocybin supply partnership4
Weiter >>
60 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1